2021 annual financial data
Galmed Pharmaceuticals 2021 Operating cash flow
Direct answer
Operating cash flow was -32,892,000 USD.
Operating income was -32,881,000 USD and net income was -32,467,000 USD.
Operating cash flow was -32,892,000 USD.
Get free Galmed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -32,881,000 USD
- Net income
- -32,467,000 USD
- Operating cash flow
- -32,892,000 USD